Robert Iannone, EVP, Global Head of R&D & CMO: Jazz Pharmaceuticals JAZZ Planned sale · Filed 08/27

Trade details

Type: Planned sale notice
Stock: Jazz Pharmaceuticals JAZZ
Person: Robert IannoneEVP, Global Head of R&D & CMO
Planned sale date: 26/08/27
Filed: 26/08/27

0.1% of shares outstanding to be sold

Jazz Pharmaceuticals trades, last 26 weeks

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 07/28~09/26

Robert Iannone's recent trades

Robert IannoneEVP, Global Head of R&D & CMO
Sell10b5-1 planJazz Pharmaceuticals
Sell10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$1.2M
7,159 sh
$1.2M
Filed 25/11/19
Traded 25/11/17
Robert IannoneEVP, Global Head of R&D & CMO
Planned sale10b5-1 planJazz Pharmaceuticals
Planned sale10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$1.2M
7,159 sh
$1.2M
Filed 25/11/17
Traded 25/11/17
Robert IannoneEVP, Global Head of R&D & CMO
SellJazz Pharmaceuticals
Sell
Jazz Pharmaceuticals
JAZZ
$332.6K
2,403 sh
$332.6K
Filed 25/03/12
Traded 25/03/10
Robert IannoneEVP, Global Head of Research a
Planned saleJazz Pharmaceuticals
Planned sale
Jazz Pharmaceuticals
JAZZ
$256.2K
1,767 sh
$256.2K
Filed 25/03/10
Traded 25/03/10
Robert IannoneEVP, Global Head of R&D & CMO
Sell10b5-1 planJazz Pharmaceuticals
Sell10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$764.6K
5,532 sh
$764.6K
Filed 25/03/07
Traded 25/03/07